An audit of growth hormone replacement for GH-deficient adults in Scotland

Clinical Endocrinology

Volumn 78, Issue 4, 2013, Pages 571-576

  Philip, Sam ^a   Howat, Isobel ^b   Carson, Maggie ^c   Booth, Anne ^a   Campbell, Karen ^b   Grant, Donna ^b   Patterson, Catherine ^d   Schofield, Christopher ^d   Bevan, John ^a   Patrick, Alan ^c   Leese, Graham ^d   Connell, John ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; AGED; CLINICAL PRACTICE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SELLA TURCICA TUMOR; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL AUDIT; CROSS-SECTIONAL STUDIES; DWARFISM, PITUITARY; GUIDELINE ADHERENCE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MIDDLE AGED; RETROSPECTIVE STUDIES; SCOTLAND; YOUNG ADULT;

EID: 84875178203     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12017     Document Type: Review

References (7)

1. Bryant, J., Loveman, E., Chase, D., et al,. (2003) Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation. Health technology assessment, 6, 1-106.
2. National Institute for Clinical Excellence (NICE) (2003) Human growth hormone (somatropin) in adults with growth hormone deficiency. 36 NICE, London. Available at: http://guidance.nice.org.uk/TA64, accessed 5 February 2012.
3. McKenna, S.P., Doward, L.C., Alonso, J., et al,. (1999) The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research, 8, 373-383.
4. Barkan, A.L., (2001) The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism? The Journal of clinical endocrinology and metabolism, 86, 1905-1907.
5. Kołtowska-Haggstrom, M., Hennessy, S., Mattsson, A.F., et al,. (2005) Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency. Hormone Research, 64, 46-54.
6. Bengtsson, B.A., Abs, R., Bennmarker, H., et al,. (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. The Journal of clinical endocrinology and metabolism, 84, 3929-3935.
7. Kołtowska-Häggström, M., Kind, P., Monson, J.P., et al,. (2008) Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysis. Clinical Endocrinology, 68, 122-129.